Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.
Subscribe to Switzer
- Switzer Report - https://switzerreport.com.au/subscribe
- Switzer Daily - https://switzer.com.au/subscribe
Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.
We got our stock pickers to show us three stocks each that they're eyeing in the new year. Here are their new financial year stocks. Plus: what's going to happen with house pricing in the near-term?
Dr Ross Walker talks us through a study that is currently being undertaken in mice for a potential vaccine for Alzheimer’s disease in the future.
Tune in to Peter Switzer and Paul Rickard for their take on the latest money news.
Peter Switzer talks to Dr Ron Weinberger, CEO and Managing Director of EMvision (EMV).
Peter Switzer speaks to Tribeca's Jun Bei Liu, Burman Invest's Julia Lee, Fairmont Equities' Michael Gable and Switzer's Paul Rickard on this week's episode of Switzer TV: Investing.
Dr Ross Walker explains what happens in the days, months and years after you quit smoking and how your risk for cancer and disease declines.
Join Peter Switzer and Paul Rickard for news and insights into the biggest money issues and how they will affect you in our latest live episode.
Adam Dawes from Shaw and Partners, Paul Rickard from Switzer and Julia Lee from Burman Invest join Peter Switzer.
Dr Ross Walker discusses the negative effects of smoking on your health and how they markedly reduce once you stop smoking.
In this week's show, Peter Switzer speaks to Jun Bei Liu, Julia Lee, Paul Rickard and Michael Terpin.
Join Peter Switzer and Paul Rickard for the latest money news in a new live episode of Mad about Money!
Peter Switzer sits down with the CEO of Novatti (NOV), Peter Cook.
Dr Ross Walker talks about another new trial into treating Glioblastoma, one of the most aggressive brain cancers.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox